Table 3A

Continued

 22:5 n-3Pre1.33 (0.52–3.36)0.66 (0.26–1.68)1.20 (0.42–3.47)0.540.70
Post0.69 (0.29–1.65)0.44 (0.17–1.12)0.82 (0.33–2.04)0.290.65
Total0.97 (0.53–1.75)0.62 (0.33–1.15)1.05 (0.55–2.02)0.300.73
 22:6 n-3Pre0.48 (0.19–1.19)0.40 (0.14–1.13)0.83 (0.27–2.58)0.250.51
Post1.21 (0.49–2.99)1.23 (0.52–2.94)0.67 (0.27–1.70)0.470.41
Total0.76 (0.41–1.41)0.79 (0.41–1.49)0.70 (0.35–1.40)0.760.49
 Total n-3fPre0.49 (0.20–1.21)0.51 (0.19–1.39)0.79 (0.29–2.18)0.350.52
Post1.30 (0.52–3.27)1.14 (0.44–2.95)0.68 (0.26–1.74)0.450.30
Total0.79 (0.43–1.44)0.80 (0.41–1.56)0.69 (0.35–1.34)0.730.30
Total n-3and n-6Pre0.52 (0.18–1.47)0.47 (0.17–1.26)0.60 (0.24–1.54)0.480.39
Post0.86 (0.39–1.87)0.85 (0.34–2.16)0.42 (0.17–1.08)0.310.09
Total0.77 (0.42–1.41)0.68 (0.36–1.30)0.59 (0.31–1.09)0.420.09
 16:0/16:1 n-7Pre0.56 (0.20–1.57)0.81 (0.31–2.13)0.68 (0.26–1.79)0.690.73
Post0.73 (0.32–1.69)0.75 (0.34–1.66)0.96 (0.39–2.33)0.820.89
Total0.69 (0.37–1.28)0.82 (0.45–1.49)0.83 (0.44–1.55)0.710.74
 18:0/18:1 n-9cPre0.55 (0.21–1.46)1.34 (0.51–3.49)1.29 (0.50–3.28)0.380.43
Post1.49 (0.61–3.62)1.07 (0.47–2.41)0.60 (0.24–1.49)0.320.25
Total0.98 (0.52–1.84)1.09 (0.59–2.01)0.85 (0.46–1.59)0.880.72
 PUFA/SFAPre0.43 (0.15–1.25)0.51 (0.19–1.30)0.45 (0.17–1.23)0.370.21
Post0.98 (0.44–2.21)0.63 (0.28–1.43)1.17 (0.49–2.76)0.520.27
Total1.11 (0.62–2.00)0.82 (0.45–1.51)0.65 (0.34–1.22)0.340.12
  • a OR adjusted for age at first full-term birth, family history of breast cancer, history of benign breast disease, and total cholesterol.

  • b Pre, premenopausal women; Post, postmenopausal women; Total, entire population (pre- + postmenopausal women).

  • c Included 14:0 + 15:0 + 16:0 + 17:0 + 18:0 + 20:0.

  • d Included 16:1 n-7c + 18:1 n-9c + 18:1 n-9t + 18:1 n-7c + 20:1 n-9.

  • e Included 18:2 n-6 + 18:3 n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6.

  • f Included 18:3 n-3 + 20:5 n-3 + 22:5 n-3 + 22:6 n-3.